Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 95 for

Edit search filters
  1. A Study of Nighttime Blood Sugar Control Patterns in Type 2 Diabetes

    Rochester, MN

  2. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort

    Eau Claire, WI, Rochester, MN, Mankato, MN, La Crosse, WI

  3. A Study of the Relationship of Markers of Cellular Senescence to Skeletal Parameters in Type 2 Diabetes Mellitus

    Rochester, MN

  4. Examination of the Pancreas in New-onset Diabetes

    Rochester, MN

  5. An Imaging Study Measuring the Form and Structure of the Layers of the Duodenum in Patients with and without Type 2 Diabetes

    Jacksonville, FL

  6. The Work of Being a Patient With Diabetes: Data Collection Via a Smartphone Application

    Rochester, MN

  7. A Study to Examine Diabetes Control and Patient Reported Outcomes Among Kidney Transplant Recipients with Type 2 Diabetes

    Rochester, MN

  8. Podocyturia in Diabetes Mellitus Type 2 and Proteinuric Glomerulonephritides

    Rochester, MN

  9. Gastric Epigenome and Transcriptome in Humans

    Rochester, MN

  10. Patient Preferences for Second-line Type 2 Diabetes Medication Treatment Outcomes

    Rochester, MN

.

Mayo Clinic Footer